• 13563 Citations
  • 54 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dae Seog Heo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 38 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Korea Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

1 Citation (Scopus)

Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib

Kim, S., Kim, T. M., Kim, D. W., Kim, S., Kim, M., Ahn, Y. O., Keam, B. & Heo, D. S., 1 Jul 2019, In : Cancer Research and Treatment. 51, 3, p. 951-962 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
1-Phosphatidylinositol 4-Kinase
Cell Line
Protein-Tyrosine Kinases
2 Citations (Scopus)

Alterations in PD-L1 expression associated with acquisition of resistance to ALK inhibitors in ALK-rearranged lung cancer

Kim, S. J., Kim, S., Kim, D. W., Kim, M., Keam, B., Kim, T. M., Lee, Y., Koh, J., Jeon, Y. K. & Heo, D. S., 1 Jul 2019, In : Cancer Research and Treatment. 51, 3, p. 1231-1240 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Lung Neoplasms
Cell Line
Non-Small Cell Lung Carcinoma
RNA Sequence Analysis
anaplastic lymphoma kinase

Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP

Cho, K. M., Keam, B., Ha, H., Kim, M., Jung, J. W., Song, W. J., Kim, T. M., Jeon, Y. K., Kang, H. R., Kim, D. W., Kim, C. W. & Heo, D. S., 1 Jul 2019, In : The Korean journal of internal medicine. 34, 4, p. 885-893 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Survival
Bone Marrow
Nursing Records

Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance

Suh, K. J., Kim, K. H., Kim, R., Byun, J. M., Kim, M., Park, J. H., Keam, B., Kim, T. M., Kim, J. S., Choi, I. S. & Heo, D. S., 1 Jul 2019, In : The Korean journal of internal medicine. 34, 4, p. 894-901 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Lymphoma, Large B-Cell, Diffuse
Costs and Cost Analysis
Recurrence
Survival
Positron Emission Tomography Computed Tomography

Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer

Choi, M., Keam, B., Ock, C. Y., Kim, M. S., Kim, T. M., Kim, D-W. & Heo, D. S., 1 Jul 2019, In : Clinical Lung Cancer. 20, 4, p. e442-e451

Research output: Contribution to journalArticleResearchpeer-review

Pemetrexed
Lung Neoplasms
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Therapeutics